Autologous stem cell transplant (ASCT) is recommended in patients with refractory or relapsed Hodgkin lymphoma (HL) [1]. In recent years, peripheral blood stem cells (PBSCs) have replaced bone marr...
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: